The combination of resveratrol and conjugated linoleic acid is not useful in preventing obesity

Journal of Physiology and Biochemistry

Volumn 67, Issue 3, 2011, Pages 471-477

  Arias, Noemi ^a,b   Macarulla, Maria Teresa ^a,b   Aguirre, Leixuri ^a,b   Martínez Castaño, María Guadalupe ^a,c   Gómez Zorita, Saioa ^a,b   Miranda, Jonatan ^a,b   Martínez, José Alfredo ^b,d   Portillo, María Puy ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL TXAGORRITXU   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Body fat; Conjugated linoleic acid; Insulin resistance; Rat; Resveratrol

Indexed keywords

CONJUGATED LINOLEIC ACID; LIPID; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; BLOOD; BODY WEIGHT; CALORIC INTAKE; DRUG COMBINATION; DRUG EFFECT; DRUG SCREENING; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; MALE; METABOLISM; OBESITY; ORGAN SIZE; PATHOLOGY; RAT; TREATMENT FAILURE; WHITE ADIPOSE TISSUE; WISTAR RAT;

ADIPOSE TISSUE, WHITE; ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; BODY WEIGHT; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; ENERGY INTAKE; GLUCOSE TOLERANCE TEST; LINOLEIC ACIDS, CONJUGATED; LIPIDS; MALE; OBESITY; ORGAN SIZE; RATS; RATS, WISTAR; STILBENES; TREATMENT FAILURE;

EID: 84856380704     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-011-0086-2     Document Type: Article

References (37)

1. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763-778 (Pubitemid 44285582)
2. Ahn J, Cho I, Kim S, Kwon D, Ha T (2008) Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. J Hepatol 49:1019-1028
3. Alcaín FJ, Villalba JM (2009) Sirtuin activators. Expert Opin Ther Pat 19:403-414
4. Bai L, Pang WJ, Yang YJ, Yang GS (2008) Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol Cell Biochem 307:129-140 (Pubitemid 350238655)
5. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342 (Pubitemid 44764104)
6. Berg AH, Scherer PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96:939-949 (Pubitemid 40712793)
7. Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G (2006) Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 17:789-810 (Pubitemid 44738517)
8. Churruca I, Fernández-Quintela A, Portillo MP (2009) Conjugated linoleic acid isomers: differences in metabolism and biological effects. Biofactors 35:105-111
9. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191-196 (Pubitemid 37150899)
10. James PT, Rigby N, Leach R, International Obesity Task Force (2004) The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 11:3-8 (Pubitemid 38388918)
11. Kennedy A, Overman A, Lapoint K, Hopkins R, West T, Chuang CC, Martínez K, McIntosh M (2009) Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol. J Lipid Res 50:225-232
12. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109-1122 (Pubitemid 44894520)
13. Larsen TM, Toubro S, Astrup A (2003) Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res 44:2234 -2241
14. Li JJ, Huang CJ, Xie D (2008) Anti-obesity effects of conjugated linoleic acid, docosahexaenoic acid, and eicosapentaenoic acid. Mol Nutr Food Res 52:631-645
15. Macarulla MT, Alberdi G, Gómez S, Tueros I, Bald C, Rodríguez VM, Martínez JA, Portillo MP (2009) Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet. J Physiol Biochem 65:369-376
16. Martin JC, Valeille K (2002) Conjugated linoleic acids: all the same or to everyone its own function? Reprod Nutr Dev 42:525-536
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
18. Miranda J, Fernández-Quintela A, Macarulla MT, Churruca I, García C, Rodríguez VM, Simón E, Portillo MP (2009) A comparison between CLNA and CLA effects on body fat, serum parameters and liver composition. J Physiol Biochem 65:25-32
19. Navarro V, Zabala A, Macarulla MT, Fernández-Quintela A, Rodríguez VM, Simón E, Portillo MP (2003) Effects of conjugated linoleic acid on body fat accumulation and serum lipids in hamsters fed an atherogenic diet. J Physiol Biochem 59:193-199
20. Navarro V, Fernández-Quintela A, Churruca I, Portillo MP (2006) The body-fat lowering effect of conjugated linoleic acid: a comparison between animal and human studies. J Physiol Biochem 62:137-147
21. Palsamy P, Sivakumar S, Subramanian S (2010) Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin -nicotinamide-induced experimental diabetic rats. Chem Biol Interact 186:200-210
22. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, Leid M, McBurney MW, Guarente L (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429:771-776 (Pubitemid 38833129)
23. Poirier H, Niot I, Clément L, Guerre-Millo M, Besnard P (2005) Development of conjugated linoleic acid (CLA)-mediated lipoatrophic syndrome in the mouse. Biochimie 87:73-79 (Pubitemid 40298768)
24. Rayalam S, Della-Fera MA, Yang JY, Park HJ, Ambati S, Baile CA (2007) Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J Nutr 137:2668-2673 (Pubitemid 350255295)
25. Rivera L, Morón R, Zarzuelo A, Galisteo M (2009) Longterm resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 77:1053-1063
26. Salas-Salvadó J, Márquez-Sandoval F, Bulló M (2006) Conjugated linoleic acid intake in humans: a systematic review focusing on its effect on body composition, glucose, and lipid metabolism. Crit Rev Food Sci Nutr 46:479-488
27. Sharma S, Misra CS, Arumugam S, Roy S, Shah V, Davis JA, Shirumalla RK, Ray A (2011) Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes. Phytother Res 25:67-73
28. Szkudelska K, Szkudelski T (2010) Resveratrol, obesity and diabetes. Eur J Pharmacol 635:1-8
29. Szkudelska K, Nogowski L, Szkudelski T (2009) Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. J Steroid Biochem Mol Biol 113:17-24
30. Szkudelski T (2008) The insulin-suppressive effect of resveratrol-an in vitro and in vivo phenomenon. Life Sci 82:430-435
31. Tai MM (1994) A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 17:152-154
32. Tchernof A (2007) Visceral adipocytes and the metabolic syndrome. Nutr Rev 65:S24-S29
33. Tresaco B, Bueno G, Moreno LA, Garagorri JM, Bueno M (2003) Insulin resistance and impaired glucose tolerance in obese children and adolescents. J Physiol Biochem 59:217-223
34. Tricon S, Burdge GC, Willimas CM, Calder PC, Yaqoob P (2005) The effects of conjugated linoleic acid on human health-related outcomes. Proc Nutr Soc 64:171-182 (Pubitemid 40813539)
35. Wang YW, Jones PJ (2004) Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Relat Metab Disord 28:941-955 (Pubitemid 38998698)
36. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808 (Pubitemid 38063703)
37. Yang JY, Della-Fera MA, Hausman DB, Baile CA (2007) Enhancement of ajoene-induced apoptosis by conjugated linoleic acid in 3T3-L1 adipocytes. Apoptosis 12:1117-1128 (Pubitemid 46701606)